Royal Bank of Canada Has $611,000 Stock Position in Innovator IBD 50 ETF $FFTY

Royal Bank of Canada boosted its position in shares of Innovator IBD 50 ETF (NYSEARCA:FFTY) by 3,222.5% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 18,274 shares of the company’s stock after buying an additional 17,724 shares during the quarter. Royal Bank of Canada owned approximately 0.79% of Innovator IBD 50 ETF worth $611,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. BNP Paribas Financial Markets bought a new position in Innovator IBD 50 ETF during the 3rd quarter worth approximately $1,494,000. Prosperity Wealth Management Inc. acquired a new stake in shares of Innovator IBD 50 ETF in the third quarter valued at approximately $637,000. HRT Financial LP bought a new stake in Innovator IBD 50 ETF during the 4th quarter worth about $507,000. JPMorgan Chase & Co. bought a new stake in Innovator IBD 50 ETF during the third quarter worth about $478,000. Finally, NewEdge Advisors LLC acquired a new stake in shares of Innovator IBD 50 ETF in the 1st quarter valued at approximately $306,000.

Innovator IBD 50 ETF Stock Down 0.2%

Shares of NYSEARCA FFTY opened at $36.85 on Tuesday. Innovator IBD 50 ETF has a twelve month low of $31.61 and a twelve month high of $44.08. The business’s 50 day moving average price is $39.19 and its two-hundred day moving average price is $38.45. The company has a market cap of $79.23 million, a PE ratio of 30.34 and a beta of 1.47.

Innovator IBD 50 ETF Company Profile

The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.